SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                          Date of Report: April 9, 2009
                        (Date of earliest event reported)

                                VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)


    Delaware                        0-18105                   11-2871434
--------------------------------------------------------------------------------
(State or other                  (Commission                 (IRS Employer
 jurisdiction of                 File Number)                Identification
 incorporation)                                                 Number)


180 Linden Avenue, Westbury, New York                           11590
-------------------------------------                           -----
(Address of principal executive offices)                      (Zip Code)



Registrant's telephone number including area code           (516) 997-4600
                                                             -------------


                                 Not applicable
                                 --------------
          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b)

[ ] Pre-commencement  communications  pursuant to Rule 13e-4c under the Exchange
Act (17 CFR 240.13e-4c)


Item 5.02  Departure of Directors or Certain  Officers;  Election of  Directors;
           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

     (b) On April 9, 2009,  the Board of Directors  accepted the  resignation of
Joseph A.  Giacalone as a member of the Board of  Directors  and Chairman of the
Audit  Committee.   Mr.   Giacalone's   resignation  was  due  to  personal  and
professional  commitments  that he believed would preclude him from devoting the
time and energy necessary to properly perform his functions as a director and as
Chairman of the Audit Committee.

                                   SIGNATURES

     Pursuant to the  requirements  of the  Securities  Exchange Act of 1934, as
amended,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                       VASOMEDICAL, INC.


                                       By: /s/  Jun Ma
                                           -------------------------------------
                                           Jun Ma
                                           President and Chief Executive Officer


Dated:   April 13, 2009